UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

[X]

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For quarterly period ended March 31,September 30, 2022


[   ]

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from _____ to _____


Commission file number: No. 0-24368


FLEXPOINT SENSOR SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

Delaware87-0620425

Delaware

87-0620425

 (State of incorporation)

(I.R.S.  Employer Identification No.)

     

5718 W Dannon Way, Suite B, West Jordan, Utah 84081

(Address of principal executive offices)


801-568-5111

(Registrant’s telephone number)


Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

None


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [ ]


Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X] No [ ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]


Non-accelerated filer [X]

Accelerated filer [ ]

Smaller reporting company [X]

Emerging growth company [ ]


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]





1




Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.

Yes [ ] No [X]


The number of shares outstanding of the registrant’s common stock was 125,557,174 as of May 16,November 14, 2022.



2




TABLE OF CONTENTS


PART I: FINANCIAL INFORMATION


Item 1.

Condensed Financial Statements

3

4

Condensed Consolidated Balance Sheets at March 31,September 30, 2022 (Unaudited) and

4

5

December 31, 2021

Condensed Consolidated Statements of Operations for the Three Months  

and Nine

5

6

Months Ended March 31,September 30, 2022 and 2021 (Unaudited)

Condensed Consolidated Statement of Stockholders’ Equity for the Three

Nine

6

7

Months Ended March 31,September 30, 2022 and 2021 (Unaudited)

Condensed Consolidated Statements of Cash Flows for the ThreeNine Months

7

8

Ended March 31,September 30, 2022 and 2021 (Unaudited)

Notes to Condensed Consolidated Financial Statements (Unaudited)

8

9

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

14

16

Item 3.

Quantitative and Qualitative Disclosure about Market Risk

18

21

Item 4.

Controls and Procedures

18

21


PART II: OTHER INFORMATION


Item 1.  Legal Proceedings21

Item 1.  

Legal Proceedings

18

Item 1A.

Risk Factors

21

Item 1A.

Risk Factors

18

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

19

21

Item 3.

Defaults upon Senior Securities

19

21

Item 4

Mine Safety Disclosures

19

22

Item 5.

Other Information

19

22

Item 6.

Exhibits

19

22

Signatures

20

23


PART I - FINANCIAL INFORMATION


ITEM 1.  CONDENSED FINANCIAL STATEMENTS

The financial information set forth below with respect to our condensed consolidated financial position as of March 31,September 30, 2022, the condensed consolidated statements of operations for the three and nine months ended March 31,September 30, 2022 and 2021, the condensed consolidated statement of stockholders’ equity for the three and nine months ended March 31,September 30, 2022 and 2021 and the condensed consolidated statements of cash flows for the threenine months ended March 31,September 30, 2022 and 2021 are unaudited. The information presented below for the condensed consolidated financial position as of December 31, 2021 was audited and reported as part of our annual filing of our Form 10-K, filed with Securities and Exchange Commission on March 31, 2022. The results of operations for the three and nine months ended March 31,September 30, 2022 and 2021, respectively, are not necessarily indicative of results to be expected for any subsequent periods.



3




FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

 CONDENSED CONSOLIDATED BALANCE SHEETS

 September 30,2022 (Unaudited) 

December 31,

2021

ASSETS   
Current Assets   
Cash and cash equivalents$                - $               402
Accounts receivable, net of allowance for bad debts of $105,790 and $105,79013,135             8,918
Deposits and prepaid expenses10,791 512
Total Current Assets23,926 9,832
Long-Term Deposits13,624 13,624
Property and Equipment, net of accumulated depreciation   
of $597,173 and $597,173- -
Goodwill4,896,917         4,896,917
Total Assets$   4,934,467  $   4,920,373
    
LIABILITIES AND STOCKHOLDERS' EQUITY   
Current Liabilities   
Bank overdraft$  19,226 $                  -
Accounts payable       259,204         226,447
Accounts payable – related party41,261 20,481
Accrued liabilities2,337,158 2,203,727
Notes payable642,776 455,000
Convertible notes payable180,000          510,000
Convertible notes payable - related party218,513             218,513
Total Current Liabilities3,698,138 3,634,168
Long-term Liabilities- -
Total Liabilities3,698,138 3,634,168
    
Stockholders' Equity   
Preferred stock – $0.001 par value; 1,000,000 shares authorized;   
no shares issued or outstanding                  -                   -
Common stock – $0.001 par value; 200,000,000 shares authorized;  

125,557,174 and 114,396,242 shares issued and outstanding,

respectively

125,557 114,396
Additional paid-in capital31,847,263      31,254,182
Accumulated deficit(30,736,491)     (30,082,373)
Total Stockholders' Equity1,236,329         1,286,205
Total Liabilities and Stockholders' Equity$    4,934,467  $     4,920,373

The accompanying notes are an integral part of these condensed consolidated financial statements

 

 March 31, 2022 (Unaudited)

 

December 31,

2021

ASSETS

 

 

 

Current Assets

 

 

 

Cash and cash equivalents

$                -

 

$               402

Accounts receivable, net of allowance for bad debts of $105,790 and $105,790

44,944

 

8,918

Deposits and prepaid expenses

12,434

 

512

Total Current Assets

57,378

 

9,832

Long-Term Deposits

13,624

 

13,624

Property and Equipment, net of accumulated depreciation

 

 

 

of $597,173 and $597,173

-

 

-

Goodwill

4,896,917

 

4,896,917

Total Assets

$   4,967,919

 

$   4,920,373

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

Current Liabilities

 

 

 

Bank overdraft

$        17,592

 

$                  -

Accounts payable

252,936

 

226,447

Accounts payable – related party

32,543

 

20,481

Accrued liabilities

2,181,666

 

2,203,727

Notes payable

450,000

 

455,000

Convertible notes payable

180,000

 

510,000

Convertible notes payable - related party

218,513

 

218,513

Total Current Liabilities

3,333,250

 

3,634,168

Long-term Liabilities

-

 

-

Total Liabilities

3,333,250

 

3,634,168

 

 

 

 

Stockholders' Equity

 

 

 

Preferred stock – $0.001 par value; 1,000,000 shares authorized;

 

 

 

no shares issued or outstanding

-

 

-

Common stock – $0.001 par value; 200,000,000 shares authorized;

 

 

 

125,557,174 and 114,396,242 shares issued and outstanding,

respectively

125,557

 

114,396

Additional paid-in capital

31,847,263

 

31,254,182

Accumulated deficit

(30,338,151)

 

(30,082,373)

Total Stockholders' Equity

1,634,669

 

1,286,205

Total Liabilities and Stockholders' Equity

$    4,967,919

 

$   4,920,373


FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

          
  For the Three Months For the Nine Months
  Ended September 30, Ended September 30,
  2022 2021 2022 2021
         
Design, Contract and Testing  Revenue $    23,957 $     55,823 $       120,896 $       155,667
         
Operating Costs and Expenses        
 Cost of revenue     6,542     6,089 30,726 29,541
Administrative and marketing expense          148,315          172,195          471,573          420,410
Research and development expense            55,665            51,379          171,877          201,061
         
Total Operating Costs and Expenses          210,522          229,663          674,176          651,012
         
Net Operating Income (Loss) (186,565) (173,840) (553,280) (495,345)
         
Other Income and Expenses        
Interest expense         (17,948)         (24,557)    (55,544)    (72,589)
Interest income - 1 - 3
Other income 300 - 900 -

Gain (Loss) on conversion/

forgiveness of debt

 - 59,500 (46,194) 119,000
Gain(Loss) on sale of assets - -         -         2,250
         
Total Other Income (Expense)         (17,648)         34,944         (100,838)         48,664
         
Net Income (Loss) $    (204,213) $    (138,896) $    (654,118) $    (446,681)
         
Basic and Diluted Loss per Common Share$          (0.00) $          (0.00) $          (0.01) $       (0.00)
         
         
Basic and Diluted Weighted-Average Common Shares        
Outstanding     125,557,174     114,396,242     122,593,612     113,320,581
         
         
         

The accompanying notes are an integral part of these condensed consolidated financial statements




FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)


 

 

For the Three Months

 

 

Ended March 31,

 

2022

 

2021

 

 

 

 

 

Manufacturing, Design and Contract Revenue

 

$    60,924

 

$    20,290

 

 

 

 

 

Operating Costs and Expenses

 

 

 

 

Cost of revenue

 

12,162

 

3,076

Administrative and marketing

 

177,879

 

129,572

Research and development

 

60,093

 

75,216

 

 

 

 

 

Total Operating Costs and Expenses

 

250,134

 

207,864

 

 

 

 

 

Loss from Operations

 

(189,210)

 

(187,574)

 

 

 

 

 

Other Income and Expenses

 

 

 

 

Interest expense

 

(20,674)

 

(23,894)

Loss on conversion of notes payable

 

(46,194)

 

-

Other income

 

300

 

1

 

 

 

 

 

Net Other Income (Expense)

 

(66,568)

 

(23,893)

 

 

 

 

 

Net Loss

 

$  (255,778)

 

$  (211,467)


Basic and Diluted Loss per

Common Share

 

$       (0.00)

 

$       (0.00)

 

 

 

 

 

Basic and Diluted Weighted Average Common Shares Outstanding

 

116,567,701

 

111,396,243



 The accompanying notes are an integral part of these condensed consolidated financial statements







FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the Three and Nine Months Ended March 31,September 30, 2022 and 2021


(UNAUDITED)


 

Common Stock

Additional Paid-in Capital


Common Stock to be Issued

 

Total Stockholder Equity

 


Shares


Amount

Accumulated Deficit


Balance – December 31, 2021


114,396,242


$ 114,396


$ 31,254,182


$          -


$ (30,082,373)


$1,286,205

 

 

 

 

 

 

 

Common stock issued for conversion of notes payable


11,160,932


11,161


 593,081


 -


-


604,242

 

 

 

 

 

 

 

Net loss – three months ended March 31, 2022


-


-


-


-


(255,778)


(255,778)

 

 

 

 

 

 

 

Balance – March 31, 2022

125,557,174

$ 125,557

$ 31,847,263

$           -

$ (30,338,151)

$ 1,634,669

 

 

 

 

 

 

 



 

Common Stock

Additional Paid-in Capital


Common Stock to be Issued

 

Total Stockholder Equity

 


Shares


Amount

Accumulated Deficit


Balance – December 31, 2020


99,713,464


$ 99,713


$ 30,882,936


$ 385,929


$ (29,394,671)


$1,973,907

 

 

 

 

 

 

 

Common stock issued in full settlement of stock conversion


14,682,778


14,683


 371,246


 (385,929)


-


-

 

 

 

 

 

 

 

Net loss – three months ended March 31, 2021


-


-


-


-


(211,467)


(211,467)

 

 

 

 

 

 

 

Balance – March 31, 2021

114,396,242

$ 114,396

$ 31,254,182

$             -

$ (29,606,138)

$ 1,762,440

 

 

 

 

 

 

 

  Common StockAdditional Paid-in Capital Total Stockholder Equity
  

 

Shares

 

Amount

Accumulated Deficit
       
Balance – December 31, 2021 114,396,242$ 114,396$ 31,254,182$ (30,082,373)$1,286,205
Common stock issued for conversion of debt 11,160,93211,161 593,081-604,242
Net loss – three months ended March 31, 2022 ---(255,778)(255,778)
       
Balance – March 31, 2022 125,557,174$ 125,557$ 31,847,263$ (30,338,151)$ 1,634,669
       
Net loss – three months ended June 30, 2022 ---(194,127)(194,127)
       
Balance – June 30, 2022 125,557,174$ 125,557$31,847,263$ (30,532,278)$ 1,440,542
       
Net loss – three months ended September 30, 2022 ---(204,213)(204,213)
       
Balance – September 30, 2022 125,557,174$ 125,557$ 31,847,263$ (30,736,491)$ 1,236,329



 Common StockAdditional Paid-in Capital

 

Common Stock to be Issued

 Total Stockholder Equity
 

 

Shares

 

Amount

Accumulated Deficit
       
Balance – December 31, 202099,713,464$ 99,713$ 30,882,936$ 385,929$ (29,394,671)$1,973,907
Common stock issued in full settlement of stock conversion14,682,77814,683 371,246 (385,929)--
Net loss – three months ended March 31, 2021----(211,467)(211,467)
       
Balance – March 31, 2021114,396,242$ 114,396$ 31,254,182$-$ (29,606,138)$ 1,762,440
       
Net loss – three months ended June 30, 2021----(96,318)(96,318)
       
Balance – June 30, 2021114,396,242$ 114,396$ 31,254,182$             -$ (29,702,456)$ 1,666,122
       
Net loss – three months ended September 30, 2021----(138,896)(138,896)
       
Balance – September 30, 2021114,396,242$ 114,396$ 31,254,182$             -$ (29,841,352)$ 1,527,226

The accompanying notes are an integral part of these condensed consolidated financial statements



6




FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)


 

 

 

For the Three Months

 

Ended March 31,

 

2022

 

2021

 Cash Flows from Operating Activities: 

 

 

 

    Net loss

$   (255,778)

 

$   (211,467)

    Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

        Depreciation

-

 

560

        Loss on conversion of notes payable

46,194

 

-

   Changes in operating assets and liabilities:

 

 

 

        Accounts receivable

(36,026)

 

5,967

        Prepaid expenses and other assets

(11,922)

 

7,595

        Accounts payable

26,489

 

(6,348)

        Accounts payable – related parties

12,063

 

4,800

        Accrued liabilities

80,986

 

90,140

 Net Cash Provided by (Used) in Operating Activities 

(137,994)

 

(108,753)


 Cash Flows from Financing Activities:

 

 

 

        Proceeds from borrowings under notes payable

120,000

 

134,500

        Proceeds from (payment of) bank overdrafts

17,592

 

(15,747)

        Payment on loans payable

-

 

(10,000)

 Net Cash Provided by Financing Activities 

137,592

 

108,753

 

 

 

 

 Net Change in Cash and Cash Equivalents

 

 

-

 Cash and Cash Equivalents at Beginning of Period

402

 

-

 Cash and Cash Equivalents at End of Period

$               -

 

$              -

 

 

 

 

 Supplemental Cash Flow Information:

 

 

 

    Cash paid for income taxes

$               -

 

$              -

    Cash paid for interest

$               -

 

$              -

Non-cash Investing and Financing Activity

 

 

 

     Common stock issued in conversion of notes payable

$   604,242

 

$              -

  
 For the Nine Months
 Ended September 30,
 2022 2021
Cash Flows from Operating Activities:    
    Net loss$   (654,118) $   (446,681)
    Adjustments to reconcile net loss to net cash used in operating activities:   
        Depreciation- 1,451
Loss (Gain) on conversion of debt46,194 (119,000)
   Changes in operating assets and liabilities:   
        Accounts receivable(4,217) (41,784)
        Prepaid expenses and other assets(10,279) (24,773)
Accounts payable32,757 18,325
        Accounts payable – related parties7,980 4,800
        Accrued liabilities236,479 244,036
Net Cash Provided by (Used) in Operating Activities (345,204) (363,626)

 

Cash Flows from Financing Activities:

   
Proceeds from borrowings under notes payable317,776 -
Proceeds from (payment of) bank overdrafts19,226 (874)
Proceeds from borrowing under convertible note payable- 384,500
Advances from related party12,800 -
Payment on loans payable(5,000) (20,000)
Net Cash Provided by Financing Activities 344,802 363,626
    
Net Change in Cash and Cash Equivalents(402) -
Cash and Cash Equivalents at Beginning of Period402 -
Cash and Cash Equivalents at End of Period$               -  $         -
    
Supplemental Cash Flow Information:   
    Cash paid for income taxes$               -  $        - 
Cash paid for interest$               -  $        - 
Non-cash Investing and Financing Activity   
     Common stock issued in conversion of debt$    604,242  $385,929















The accompanying notes are an integral part of these condensed consolidated financial statements



7




FLEXPOINT SENSOR SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31,SEPTEMBER 30, 2022

(UNAUDITED)


NOTE 1SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Condensed Consolidated Interim Financial Statements – The accompanying unaudited condensed consolidated financial statements include the accounts of Flexpoint Sensor Systems, Inc. (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Flexpoint Sensor Systems, Inc. for the year ended December 31, 2021 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on March 31, 2022. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2022.


Nature of Operations – Flexpoint Sensor Systems, Inc. (the Company) is located in West Jordan, Utah. The Company’s activities to date have included acquiring equipment and enhancing technology, obtaining financing, limited production and seeking long-term manufacturing contracts. The Company’s operations are in designing, engineering, manufacturing and selling sensor technology and equipment using flexible potentiometer technology. Through March 31,September 30, 2022, the Company continued to manufacture products and sensors to fill customer orders and provide engineering and design work.


The COVID-19 Pandemic (“the Pandemic”) has had a dramatic effect on our business as well as the business of our customers. The wide-ranging effects on the world-wide business market has led to a general reluctance for businesses to move forward with entering into major commitments until their future markets have been clarified. Because of this, we have experienced a significant slowdown in the size and number of orders received and, while we cannot predict when the influence of the Pandemic will end, we expect that orders will return to their former levels and increase following a return to normal business operations.


Principles of Consolidation – The accompanying financial statements include the accounts of Flexpoint Sensor Systems, Inc. and its wholly-owned subsidiary, Flexpoint International, LLC. Intercompany transaction and accounts have been eliminated in consolidation.

Use of Estimates – The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods.  Actual results could differ from those estimates.


Cash and Cash Equivalents – Cash and cash equivalents are considered to be cash and highly liquid securities with original maturities of three months or less.


Fair Value MeasurementsThe fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. The fair value should be calculated based on assumptions that market participants would use in pricing the asset or liability, not on assumptions specific to the entity. In addition, the fair value of liabilities should include consideration of non-performance risk, including the party’s own credit risk.

 

Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:

 

Level 1: Quoted market prices in active markets for identical assets or liabilities.

 

Level 2: Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or



8




model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities.


Level 3: Unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.


To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.


The carrying value of the Company’s cash, accounts payable, short-term borrowings (including convertible notes payable), and other current assets and liabilities approximate fair value because of their short-term maturity.


Accounts Receivable – Trade accounts receivable are recorded at the time product is shipped or services are provided including any shipping and handling fees. Contracts associated with design, development engineering and manufacturing generally require a deposit of 50% of the quoted price prior to the commencement of work. The deposit is considered deferred income until the entire project, or the appropriate portion of the contract to meet scheduled deliveries is completed and shipped, and accepted by the customer, at which time the entire contract price, or the appropriate portion of the contract, is billed to the customer and the deposit applied. The Company has established an allowance for bad debts based on a historical experience and an analysis of risk associated with the account balances. The balance in the allowance account was $105,790 and $105,790 as of March 31,September 30, 2022 and December 31, 2021, respectively.


Inventories – The Company does not currently have inventory. However, as production levels increase inventories will be carried on the balance sheet. Inventories will be stated at the lower of cost or market or net realizable value. Cost is determined by using the first in, first out (FIFO) method.


Property and Equipment –Equipment– Property and equipment are stated at cost.  Additions and major improvements are capitalized while maintenance and repairs are charged to operations.  Upon trade-in, sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is recognized. Depreciation is computed using the straight-line method and is recognized over the estimated useful lives of the property and equipment, which range from three to ten years.


Valuation of Long-lived Assets – The carrying values of the Company’s long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that they may not be recoverable. When projections indicate that the carrying value of the long-lived asset is not recoverable, the carrying value is reduced by the estimated excess of the carrying value over the projected discounted cash flows. Under similar analysis no impairment charge was taken during the three-monthnine-month period ended March 31,September 30, 2022 and during the year ended December 31, 2021. Impairment tests will be conducted on an annual basis and, should they indicate a carrying value in excess of fair value, additional impairment charges may be required.


Intangible Assets – Costs to obtain or develop patents are capitalized and amortized over the remaining life of the patents, and technology rights are amortized over their estimated useful lives. The Company currently has the right to several patents and proprietary technology.  Patents and technology are amortized from the date the Company acquires or is awarded the patent or technology right, over their estimated useful lives, which range from 5 to 15 years.  An impairment charge is recognized if the carrying amount is not recoverable and the carrying amount exceeds the fair value of the intangible assets as determined by projected discounted net future cash flows. Under similar analysis there was no impairment charge taken during the three-monthnine-month period ended March 31,September 30, 2022 and during the year ended December 31, 2021.


Research and DevelopmentResearch and development costs are recognized as an expense during the period incurred, which is until the conceptual formulation, design, and testing of a process is completed and the process has been determined to be commercially viable.


10 

Lease Obligations – While the Company has adopted ASC 842 the Company has no leases at the date of this report that are required to be reported under ASC 842. As the Company enters into such leases it will record obligations under all leases it has entered into pursuant to the reporting requirements under ASC 842, allocating such obligations between current and long term.




Goodwill– Goodwill represents the excess of the Company’s reorganization value over the fair value of net assets of the Company upon emergence from bankruptcy. Goodwill is not amortized, but is tested for impairment annually, or at interim periods when a triggering event occurs using a fair value approach. According to Accounting Standards Codification (or “ASC”) 350-20 Intangibles – Goodwill and Other, a fair-value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. This test requires various judgments and estimates. The fair value of the Company is allocated to the Company’s assets and liabilities based upon their fair values with the excess fair value allocated to goodwill. An impairment of goodwill is measured as the excess of the carrying amount of goodwill over the determined fair value.


Revenue Recognition – On January 1, 2018, the Company adopted ASC 606, Revenue from Contracts with Customers, and all of the related amendments (“new revenue standard”). We have applied the new revenue standard to all contracts as of the date of the initial adoption. The new revenue standard establishes five steps whereby a transaction is analyzed to determine if revenue has been earned and can be recognized. The adoption of the new revenue standard did not have any effect on our financial statements. The vast majority of our sales are made to order, for which orders we require a deposit of 50% of the value of the order. That amount is put in a customer deposit account until the entire order has been manufactured and shipped or the appropriate portion of the project is completed to meet scheduled deliveries, invoiced and shipped. At the ship date, the Company has no further obligations under that portion of the contract and the revenue from the sale is recognized.


A part of our customer base is made up of international customers. The table below allocates revenue between domestic and international customers. The following table presents Flexpoint Sensor Systems revenues disaggregated by region and product type:

 

Three months ended:Three months ended: March 31, March 31,Three months ended: September 30, September 30,
   2022    2021   2022    2021 
         
 ConsumerLong-term  ConsumerLong-term  ConsumerLong-term ConsumerLong-term 
Segments  ProductsContractTotal  ProductsContractTotal ProductsContractTotal ProductsContractTotal
Domestic $10,441-10,441 $8,261-8,261 $18,454-18,454 $631-631
International  50,483-50,483  12,029-12,029  5,503-5,503 55,192-55,192
 $60,924-60,924 $20,290-20,290 $23,957-23,957 $55,823-55,823
    
        
Components 60,924-60,924 19,290-19,290 6,968-6,968 55,823-55,823
Engineering Services  --- 1,000-1,000 16,989-16,989 ---
 $60,924-60,924 $20,290-20,290 $23,957-23,957 $55,823-55,823


11 

Nine months ended: September 30,   September 30,
    2022     2021 
        
   ConsumerLong-term    ConsumerLong-term 
Segments  ProductsContractTotal   ProductsContractTotal
Domestic $31,728-31,728  $25,953-25,953
International  89,168-89,168   129,714-129,714
  $120,896-120,896  $155,667-155,667
            
            
Components  91,214-91,214   154,667-154,667
Engineering Services  29,682-29,682   1,000-1,000
  $120,896-120,896  $155,667-155,667

Basic and Diluted Loss Per Share – Basic loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the period.  Diluted loss per share is computed by dividing net loss by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At March 31,September 30, 2022 and 2021 there were outstanding common share equivalents (options and convertible notes payable) which amounted to 10,849,00811,043,870 and 18,605,54817,497,193 of common stock, respectively. These common share equivalents were not included in the computation of diluted earnings per share for the three-monththree and nine-month periods ended March 31,September 30, 2022 and 2021 as their effect would have been anti-dilutive, thereby decreasing loss per common share.


Concentrations and Credit Risk - The Company has a few major customers who represent a significant portion of revenue, accounts receivable and notes receivable. During the three-monthnine-month period ended March 31,September 30, 2022, twofour customers represented 74%81% of sales and two customers represented 93%97% of accounts receivable. The Company has a strong ongoing relationship with these customers with scheduled delivery extending through the year and does not believe this concentration poses a significant risk, as their products are based entirely on the Company’s technologies.


Income Taxes - The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards Board Accounting Codification (ASC) 740: Income Taxes. Deferred tax assets and liabilities are



10




measured using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets will be reflected on the balance sheet when it is determined that it is more likely than not that the asset will be realized


Recent Accounting Pronouncements–On August 20, 2020 the FASB released ASU 2020-06 “Simplified Convertible Instrument Framework”. This pronouncement simplifies the convertible debt accounting framework, eliminating, among other things, the beneficial conversion feature model. The adoption date of this pronouncement is for fiscal years beginning after December 15, 2023, but allows for earlier adoption for fiscal years beginning after December 31, 2020. The Company has elected to adopt this accounting treatment effective January 1, 2021. Its adoption will have a beneficial effect on its financial statements in those instances when the conversion rate set by convertible notes is below the market price on the date the convertible note is issued, as no beneficial conversion expense will be recorded.


The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.


NOTE 2 –2– GOING CONCERN


The Company continues to accumulate significant operating losses and has an accumulated deficit of $30,338,151$30,736,491 at March 31,September 30, 2022.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.

12 

concern for a period of one year from the issuance of these financial statements. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.


Management is seeking additional funding to provide operating capital for its operations until such time as revenues are sufficient to sustain our level of operations.  However, there is no assurance that additional funding will be available on acceptable terms, if at all.


NOTE 3 – NOTES PAYABLE


During the threenine months ended March 31,September 30, 2022, the Company received fourten payments of $25,000 each, two payments of $20,000 and one payment of $20,000,$27,776, for a total of $120,000,$317,776, from onetwo of the convertible note holders as working capital loans to enable the Company to meet its obligations for operating expenses. In March 2022 the holders of $125,000 on notes payable elected to convert the principal and $12,068 of accrued interest into 2,741,385 shares of common stock, resulting in a loss of $13,060 on conversion. While it is the intent of both parties to enter into a convertible note on the remaining advances, of which these payments will be a part, no terms, either as to conversion rate, interest rate, or maturity date has been agreed upon as of this date. Until such agreement is reached, the balance of $415,000$612,776 as of March 31,September 30, 2022 is unsecured, non-interest bearing and due on demand. At September 30, 2022 there is $48,265 in accrued unpaid interest relating to these notes.


In August 2020 the Company received $50,000 from a large shareholder to meet operating expenses. The shareholder indicated that he would want the $50,000 loan repaid when the Company was in a position to do so. The shareholder subsequently provided an additional $5,000, for a total loan of $55,000. The balance is non-interest bearing and due on demand. During the three-monthyear ended December 31, 2021, payments totaling $20,000 were made, and during the nine-month period ended March 31,September 30, 2022, no payments werea $5,000 payment was made against the loan, leaving a remaining balance of $35,000$30,000 which is non-interest bearing and due on demand.


NOTE 4 – CONVERTIBLE NOTES PAYABLE


Convertible Notes Payable


At March 31,September 30, 2022, there are notes outstanding with principal balances which total $180,000. Of the notes, $140,000 are convertible notes bearing a 10% annual rate of interest (with a 15% default rate). Of these notes, $100,000 is convertible into shares of common stock at the rate of $0.05 per share and $40,000 is convertible at $0.07 per share. The remaining $40,000 is a convertible note entered into on August 8, 2011 with a former Company Director, at a conversion rate of $0.20 per share. That note was due on December 31, 2015 and bears a default interest rate of 10%. The notes are in default and interest is accrued at the default rate. At September 30, 2022 there is $120,088 in accrued unpaid interest relating to these convertible notes.


In March 2022 the holders of $330,000 in convertible notes elected to convert the principal and $90,979 of accrued interest into 8,419,547 shares of restricted common stock. The Company recorded a loss on conversion of debt of $33,034 related to these transactions.

Convertible Note Payable - Related Party


At March 31,September 30, 2022, there are notes outstanding with two directors of the Company with balances of $164,257 and $54,257, respectively. The notes bear an 8% annual rate of interest with a 12% default rate and are convertible into shares of restricted common stock. Of the notes, $114,514 is convertible into shares of restricted common stock at



11




$0.07 $0.07 per share and $104,000 of the notes are convertible at $0.06 per share. All of these notes have a maturity date of March 31, 2022.2023. Therefore, the default rate of interest was not used in accruing interest due on these notes. At September 30, 2022 there is $81,238 in accrued unpaid interest relating to these related party convertible notes.


NOTE 5 STOCK OPTION PLANS


On August 25, 2005, the Board of Directors of the Company approved and adopted the 2005 Stock Incentive Plan (the Plan). The Plan became effective upon its adoption by the Board and continued in effect for ten years, terminating on August 25, 2015.  This plan was approved by the stockholders of the Company at their annual meeting of shareholders on November 22, 2005. Under the Plan, the exercise price for all options issued will not be less than the average quoted closing market price of the Company’s trading common stock for the thirty-day period immediately preceding the grant date plus a premium of ten percent.  The maximum aggregate number of shares that may be awarded under the plan is 2,500,000 shares. The Company continues to utilize the Black-Scholes option-pricingoption-

13 

pricing model for calculating the fair value of the options granted as defined by ASC Topic 718, which is an acceptable valuation approach under ASC 718. This model requires the input of subjective assumptions, including the expected price volatility of the underlying stock.


On August 24, 2015, the Board of Directors approved the issuance of options to purchase 2,185,000 shares of the Company’s common stock. Of the total issued, 1,960,000 options were issued to replace options held by directors and employees which were to expire and 225,000 options were issued to new employees. Of the options issued, 640,000 have an option price of $0.14 per share, 500,000 have an option price of $0.15 per share, 995,000 have an option price of $0.20 per share, and 50,000 have an option price of $0.25 per share. Options issued as replacement shall have immediate vesting terms. Options which are not replacements shall vest over a two-year, four-month period in equal installments on the last day of 2015, 2016 and 2017, respectively.

 

Projected data related to the expected volatility and expected life of stock options is based upon historical and other information, and notably, the Company's common stock has limited trading history. Changes in these subjective assumptions can materially affect the fair value of the estimate, and therefore, the existing valuation models do not provide a precise measure of the fair value of the Company's employee stock options.


Between August 25, 2005 and August 25, 2019, the Company granted options to employees to purchase an aggregate 3,096,000 shares of common stock at exercise prices ranging from $0.15 to $2.07 per share. The options all vested by December 31, 2017 and expire 10 years from the date of grant.


On December 30, 2020 the Board of Directors approved the revaluation of all outstanding stock options, reducing the option price to $0.05 per share. The Company recorded a charge of $8,203 as the result of this change.


As of the years ended December 31, 2005 through 2020, the Company recognized a total of $2,451,971 of stock-based compensation expense, which includes charges of $8,203 in 2020, leaving $0 in unrecognized expense as of December 31, 2021. There were 1,900,000 employee stock options outstanding at March 31,June 30, 2022.  


A summary of all employee options outstanding and exercisable under the plan as of March 31,September 30, 2022 is set forth below:

Options

Shares

Weighted Average Exercise Price

Weighted Average Remaining Contractual Life (Years)

Aggregate Intrinsic Value

SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Life (Years)Aggregate Intrinsic Value

 

 

 

 

   

Outstanding at the beginning of period

1,900,000

 $           0.05

3.65

 $              --   

1,900,000 $                0.053.65 $              --   

Granted

--   

--   

--   

--   

                     --                                --                      --                    --   

Expired

--   

--   

--   

--   

                     --                                --                      --                    --   

Forfeited

--   

--   

--   

--   

--                             --                      --                    --   

Outstanding at the end of Period

1,900,000

 $            0.05

3.41

$              --   

       1,900,000 $                 0.052.90$               --   

Exercisable at the end of Period

1,900,000

 $            0.05

3.41

$              --   

1,900,000 $                 0.052.90 $               --  


NOTE 6 – CAPITAL STOCK


Preferred Stock – There are 1,000,000 shares of preferred stock with a par value of $0.001 per share authorized. At March 31,September 30, 2022 and December 31, 2021, there were no shares of preferred stock issued or outstanding.




Common Stock – There are 200,000,000 shares of common stock with a par value of $0.001 per share authorized. At March 31,September 30, 2022 and December 31, 2021, there were 125,557,174 and 114,396,242 shares of common stock issued and outstanding, respectively. The Company issued 11,160,932 shares of restricted common stock during the threenine months ended March 31,September 30, 2022 for the retirement of $445,000 of notes payable and convertible notes, and $103,047 of accrued interest. See also Note 4.


NOTE 7 –7– COMMITMENTS AND CONTINGENCIES


The Company currently occupies approximately 8,029 square feet of office and manufacturing space leased from D&M Management, Inc. The building is located in a commercial business district in West Jordan, Utah which consists primarily of high-tech manufacturing firms and it is located adjacent to a major intersection, allowing easy access to Utah’s main interstate highway. The original lease iswas for $6,787 per month and iswas for a period of

14 

twelve months, with a termination date of August 31, 2022. A new lease for a period of twelve months to commence September 1, 2022 at a monthly rate of $6,657 was entered into on June 20, 2022. The lease has an expiration date of August 31, 2023 and contains a 90-day notice clause if our intent is to either terminate the lease or renew the lease for one additional periods.three-year term.


The Company evaluated the lease under the new lease accounting standard and determined that it was a short-term lease due to the twelve monthtwelve-month term and the 90-day notice of termination clause.


NOTE 8 – RELATED PARTY TRANSACTIONS


At March 31, 2021,September 30, 2022, there was $32,543$40,261 payable to the Chief Executive Officer. During the nine-months ended September 30, 2022 the Chief Executive Officer provided $11,800 to be used for operating expenses, and also submitted expense reports for company obligations which he paid with his personal credit card. At December 31, 2021, the Company had amounts of $20,481$40,261 payable to its Chief Executive Officer for funds provided to meet the operating expense obligations of the Company.

At September 30, 2022, there was $1,000 payable to the Chairman of the Board. During the nine-months ended September 30, 2022 the Chairman of the Board provided $1,000 to be used for operating expenses.


NOTE 9 – SUBSEQUENT EVENTS


In AprilOctober and November, 2022, the Company received $25,000$75,000 in additional funding from a holderholders of convertible notes. There has not been a note written on these funds, and no terms have been agreed to. The funding is to bear interest at the rate of 10% per annum. The Company is recording the receipt of the funding as an on demand notenotes until such time as terms are agreed upon by the parties.





15 

13




In this quarterly report references to “Flexpoint", "the Company," “we,” “us,” and “our”refer to Flexpoint Sensor Systems, Inc. and its subsidiaries.


FORWARD LOOKING STATEMENTS


The U.S. Securities and Exchange Commission (“SEC”) encourages reporting companies to disclose forward-looking information so that investors can better understand future prospects and make informed investment decisions.  This report contains these types of statements. Words such as “may,” “expect,” “believe,” “anticipate,” “estimate,” “project,” or “continue” or comparable terminology used in connection with any discussion of future operating results or financial performance identify forward-looking statements.  You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report.  All forward-looking statements reflect our present expectation of future events and are subject to a number of important factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.


ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


EXECUTIVE OVERVIEW


Flexpoint Sensor Systems, Inc. is a company engaged principally in improving its unique sensor technology, expanding its suite of products, developing new sensor applications, obtaining financing and seeking long-term sustainable manufacturing contracts, licensing agreements and royalty agreements.  Our operations have not yet commenced to a commercially sustainable level and include designing, engineering, manufacturing, licensing and selling sensor technology and products featuring our Bend Sensor® technology and equipment.

 

Finalizing long-term, constant revenue generating production contracts with our existing and other customers remains our greatest challenge because our on-going business is dependent on the types of revenues and cash flows generated by such contracts. Cash flow and cash requirement risks are closely tied to and are dependent upon our ability to attract significant long-term production contracts. We must continue to obtain funding to operate and expand our operations so that we can deliver our unique Bend Sensor® and Bend Sensor® related technologies and products to the market.  Management believes that even though we are making positive strides forward with our business plan we will need to raise additional operating capital.

 

Worldwide automakers are faced with the challenge of providing a safer, more energy efficient, longer lasting product that consumers can afford. This has required automakers to search new and innovative ways to lower the overall weight of the vehicle and to improve its fuel efficiencies, while lowering the cost. We continue to experience an increased interest regarding automotive and other potential applications for our sensor technology because they meet this criterion. With its versatility, light weight, single layer construction and the fact that it is currently being used in various safety devices the Bend Sensor® is positioned well to meet the challenges that the automobile industry is facing.


LIQUIDITY AND CAPITAL RESOURCES


The challenges posed by the Pandemic in the United States and global economies increased significantly as the first quarter progressed. Since the onset of the Pandemic, our top priority has been the health and safety of our employees. During this difficult time, we have worked to ensure that our customers continue to receive quality, personalized service.


The Pandemic negatively impacted our revenue during the first threenine months of 2022. At this time, it is impossible to accurately predict when this will end. Many of our clients, to protect their employees, have sharply curtailed operations and have most employees working from home. The long-term impact of the Pandemic is difficult to assess at this point, as it will be dependent on how rapidly our clients can resume their business operations and place orders with us for the needed sensors incorporated into their products.


Currently our revenue is primarily from product licensing, development, manufacturing and recurring sales with additional contributions to income from design contract, testing and limited production services for prototypes and samples, and is currently at a level to support our operations.  Depending upon the world returning to some form of normalcy following the end of the Pandemic, we believe, based upon current orders and projected orders over the



16 

14




next twelve months, that we could be producing sensors under long-term contracts in the future that will help support our existing operations and potential future growth. Management recognizes such contracts usually go through a long negotiation process and there can be no guarantee that we will be successful in our negotiations or that such contracts will be sufficient to support our current operations in the near future.


In 2022, we relied on the proceeds of convertible loans from existing shareholders, which funds are accounted for as demand notes. The balances of the non-related party convertible notes have a combined total of $180,000 as of March 31,September 30, 2022. The notes have an annual interest rate of 8% to 10% and default rates of 10% to 15%, have various maturity dates, and are secured by the Company’s business assets. The on-demand notes have a principal balance of $450,000$642,776 at March 31,September 30, 2022 and no terms have yet been established for these funds.


Management believes that our current cash burn rate is approximately $60,000 per month and expectations are that it will continue at this rate for the foreseeable future. If the Pandemic ends and business returns to pre-Pandemic levels, with proceeds from additional convertible notes and estimated revenues for manufacturing, production, engineering design and prototype products should be sufficient to fund the next twelve months of operations. Our auditors have expressed doubt about our ability to continue as a going concern and that we may not realize significant revenue or become profitable within the next twelve months. We will require additional financing to fund our short-term cash needs. We will have to rely on additional debt financing, loans from existing shareholders and private placements of common stock for additional funding. Based upon our anticipated purchase orders over the next twelve months the revenue generated will not be sufficient to cover our operating expenses, based on our current burn rate. However, we cannot assure that we will be able to obtain short-term financing, or that sources of such financing, if any, will continue to be available, and if available, that they will be on terms favorable to us. Nor is there any guarantee that the projected volume of purchase orders will meet the volumes that we anticipate.


As we enter into new agreements, we must ensure that those agreements provide adequate funding for any pre-production research and development and manufacturing costs. If we are successful in establishing agreements with adequate initial funding, management believes that our operations for the long term will be funded by revenues, licensing fees and/or royalties related to these agreements. However, we have formalized only a few agreements during the past four years and there can be no assurance that the agreements will generate sufficient revenues or be profitable in the future or that a desired technological application will be successful enough to produce the volumes and profits necessary to fund our operations.


FINANCIAL OBLIGATIONS AND CONTINGENT LIABILITIES


Our principal commitments at March 31,September 30, 2022 consisted of our operating lease of $6,787$6,657 per month, and total liabilities of $3,333,250,$3,698,139, which includes $398,513 of convertible notes payable. Accrued liabilities at March 31,September 30, 2022, were $2,181,666$2,337,158 and were related to payroll, payroll tax liabilities, accrued professional expenses, accrued insurance expense, accrued interest expense on notes and accrued paid time off.


In August 2020 the Company received $50,000 from John Kelley, a large shareholder, to meet operating expenses. Mr. Kelly indicated that he would want the $50,000 loan repaid when the Company was in a position to do so. Mr. Kelly subsequently provided an additional $5,000, for a total loan of $55,000. This loanfunding has not formally been documented by a note at the time of this filing, and there is no term or interest on the note. In 2021 payment of $20,000 was made to reduce the loan balance. During the three-monthnine-month period ended March 31,September 30, 2022, no payments werea payment of $5,000 was made to reduce this loan,obligation, leaving a remaining balance of $35,000.$30,000.


The Company has received $642,776 in funding from holders of our convertible notes. These fundings have not yet been memorialized into convertible notes. The only term agreed upon to date is that all funds advanced will bear interest at the rate of 10% per annum from the date of deposit.

The Company has a few major customers who represent a significant portion of revenue and accounts receivable. During the threenine months ended March 31,September 30, 2022, twofour customers represented 74%81% of sales and two customers represented 93%97% of accounts receivable. The Company has a strong ongoing relationship with these customers with scheduled product deliveries extending through the year from one of the customers with an account receivable and does not believe this concentration poses a significant risk, as their products are based entirely on the Company’s technologies.


17 

OFF-BALANCE SHEET ARRANGEMENTS


We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.




15




CRITICAL ACCOUNTING ESTIMATES


Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”)The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Estimates of particular significance in our financial statements include goodwill and the annual tests for impairment of goodwill and long-lived assets and valuing stock option compensation.


ASC 350-20 “Intangibles – Goodwill and Other: The Company follows the guidance provided by ASC 350-20. The Company's goodwill represents the excess of its reorganization value over the fair value of the net assets upon emergence from bankruptcy. Goodwill is not amortized; therefore, we test our goodwill for impairment annually or when a triggering event occur using a fair value approach. A fair value-based test is applied at the overall Company level. The test compares the fair value of the Company to the carrying value of its net assets. The test requires various judgments and estimates. During 2021 and for the threenine months ended March 31,September 30, 2022, the Company recorded no impairment charge to reduce the carrying value of the goodwill to its estimated fair value. As part of the impairment testing performed at December 31, 2021, the Company considered factors such as the global market volatility, variables in the economy, and the overall uncertainty in the markets that has resulted in a decline in the market price of the Company's stock price and market capitalization for a sustained period, as indicators for potential goodwill impairment.


ASC 820 Fair Value Measurement:We test long-lived assets for impairment annually or when a triggering event occurs. Impairment is indicated if undiscounted cash flows are less than the carrying value of the assets. The amount of impairment is measured using a discounted-cash-flows model considering future revenues, operating costs and risk-adjusted discount rate and other factors. The analysis compares the present value of projected net cash flows for the remaining current year and next two years against the carrying value of the long-lived assets. If the carrying values of the long-lived assets exceed the present value of the discounted projected revenues an impairment expense would be recognized in the period and the carrying value of the assets would be adjusted accordingly. Impairment tests are conducted on an annual basis and, should they indicate a carrying value in excess of fair value, a charge may be required.


ASC 718 “Compensation – Stock Compensation: Financial accounting standards require that recognition of the cost of employee services received in exchange for stock options and awards of equity instruments be based on the grant-date fair value of such options and awards and is recognized as an expense in operations over the period they vest. The fair value of the options we have granted is estimated at the date of grant using the Black-Scholes American option-pricing model. Option pricing models require the input of highly sensitive assumptions, including expected stock volatility. In addition, our stock options have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimate.  Management believes the best input assumptions available were used to value the options and that the resulting option values are reasonable. For the three-monthnine-month periods ended March 31,September 30, 2022 and 2021, we recognized $0 and $0, respectively, of stock-based compensation expense for our stock options and there is no additional unrecognized compensation cost related to employee stock options at the current time.


RESULTS OF OPERATIONS


The Company continues to concentrate its marketing resources on a limited number of customers that have the greatest potential to generate the most short-term revenue while still building relationships with our larger customers. Management believes this approach has the highest potential to bring long-term commercially viable products to market and will provide sustainable cash flow to fund the Company's operations in the future. Currently, overall revenues are not sufficient to sustain our operations. The Pandemic has had a dramatic effect on our business as well as the business of our customers. The wide-ranging effects on the world-wide business market has led to a general reluctance for businesses to move forward with entering into major commitments until their future markets have been clarified. Because of this, we have experienced a

18 

significant slowdown in the size and number of orders received and, while we cannot predict when the influence of the Pandemic will end, we expect that orders will return to their former levels and increase throughout the remainder of 2022 following a return to normal business operations.Following a return to normal business operations in the world, management anticipates that revenues will increase as we continue to execute our long-term business plan and cultivate larger customer bases with our existing product offering. However, until the Pandemic ends and a long-term production contract is in place there is no guarantee that our current customer base will order in sufficient volumes to sustain our operations.



16




Therefore, management continues to work with larger companies and industries and is hopeful that in the near future we will sign a long-term licensing or manufacturing contract.


We recognized revenue from repeat orders from our existing customers, design contract, and development engineering. Revenue is recognized using the ASC 606 five step detailed in Note 1 to the financial statements. Revenue from the sale of a product is recorded at the time of shipment to the customer.  Revenue from the license agreements was recognized in the period the agreement was concluded, as it is a right of use license and the Company has no further obligations to perform under the terms of the agreement. Revenue from research and development engineering contracts is recognized as the services are provided and accepted by the customer. Revenue from contracts to license technology to others is deferred until all conditions under the contract are met and then the sale is recognized as licensing royalty revenue over the remaining term of the contract.


The following discussions are based on the consolidated operations of Flexpoint Sensor Systems, Inc. and should be read in conjunction with our unaudited financial statements for the three and nine months ended March 31,September 30, 2022 and 2021, included in Part I, Item 1, above, and the audited financial statements included in the Company’s annual report on Form 10-K for the years ended December 31, 2021 and 2020.


THREE MONTH PERIODS ENDED MARCH 31,SEPTEMBER 30, 2022 AND 2021


SUMMARY OF OPERATING RESULTS

SUMMARY OF OPERATING RESULTS

SUMMARY OF OPERATING RESULTS


Three-month period ended

 

Three-month period ended

March 31, 2022

 

March 31, 2021

September 30, 2022 September 30, 2021

Manufacturing, design, licensing and contract revenue

$         60,924

 


$          20,290

$            23,957 

 

$ 55,823

Total operating costs and expenses

250,134

 

207,864

210,522 229,663

Net other income (expense)

(66,568)

 

(23,893)

(17,648) 34,944

Net loss

(255,778)

 

(211,467)

(204,213) (138,896)

Basic and diluted loss per common share

$          (0.00)

 

$            (0.00)

$           (0.00) $             (0.00)


For the three months ending March 31,September 30, 2022, revenue was $60,924, an increase$23,956, a decrease of $40,634$31,867 when compared to the revenue of $55,823 for the same period in 2021. The majority of the revenue variance for this period is attributable to ordersordering delays from customers who are beginning to manufacture products incorporating our products.


Of the $250,134$210,522 and $207,864$229,663 total operating costs and expense for the three months ending March 31,September 30, 2022 and 2021, respectively, $60,093$55,665 and $75,216$51,379 were for direct research and development cost, respectively. For the three months ended March 31,September 30, 2022, total operating expenses decreased by $19,141 when compared to the same period in 2021, decreases in payroll, building rent and advertising comprising the largest part of the decreased expense level, with increases in professional fees and a number of other accounts resulting in the small net increase.

Other expense for the three-month period ended September 30, 2022 was $17,648, a $52,592 increase resulting, primarily from $59,000 gain on extinguishment of debt recognized in 2021.

A net loss of $204,213 was realized for the three months ended September 30, 2022. A net loss of $138,896 was realized for the three-month period ended September 30, 2021.

19 

NINE MONTH PERIODS ENDED SEPTEMBER 30, 2022 AND 2021

SUMMARY OF OPERATING RESULTS
 

 

Nine-month period ended

 September 30, 2022 September 30, 2021
Manufacturing, design, licensing and contract   revenue$            120,896 

 

$ 155,667

Total operating costs and expenses674,176 651,012
Net other income (expense)(100,838) 48,664
Net loss(654,118) (446,681)
Basic and diluted loss per common share$           (0.01) $             (0.00)

For the nine months ending September 30, 2022, revenue was $120,896, a decrease of $34,771 when compared to the same period in 2021. The majority of the revenue variance for these periods is attributable to orders from customers who are beginning to manufacture products incorporating our products.

Of the $674,176 and $651,012 total operating costs and expense for the nine months ending September 30, 2022 and 2021, respectively, $171,877 and $201,061 were for direct research and development cost, respectively. The decrease in research and development expense in 2022 results primarily from the lower lease expenses at the facility moved into in September 2021. For the nine months ended September 30, 2022, total operating expenses increased by $42,270$23,164 when compared to the same period in 2021, increases in payrollprofessional fees and professional feesinsurance comprising the largest part of the increased expense level.


Other expense for the three-monthnine-month period ended March 31,September 30, 2022 was $66,568,$100,838 while there was other income of $48,664 for the nine-months ended September 30, 2021, a $42,675 increase$149,502 difference resulting, primarily, from a $46,194 loss on note conversion.  conversion in 2022 and a $119,000 gain on extinguishment of debt in 2021.


A net loss of $255,778$654,118 was realized for the threenine months ended March 31,September 30, 2022. A net loss of $211,467$446,681 was realized for the three-monthnine-month period ended March 31,September 30, 2021.


The chart below represents a summary of our condensed consolidated balance sheets at March 31,September 30, 2022 and December 31, 2021.


SUMMARY OF BALANCE SHEET INFORMATION

SUMMARY OF BALANCE SHEET INFORMATION

SUMMARY OF BALANCE SHEET INFORMATION

 

 

 

   

March 31, 2022

 

December 31, 2021

September 30, 2022 December 31, 2021

Cash and cash equivalents

$                      -

 

$             402  

$                        - $              402  

Total current assets

57,378 

 

9,832 

23,926  9,832 

Total assets

4,967,919

 

4,920,373

4,934,467 4,920,373

Total liabilities

3,333,250

 

3,634,168

            3,698,138 3,634,168

Accumulated deficit

 (30,338,151)

 

 (30,082,373)

       (30,736,491)          (30,082,373)

Total stockholder’s equity

 $       1,634,669

 

 $     1,286,205

 $           1,236,329  $      1,286,205


Cash at March 31,September 30, 2022 was overdrawn by $17,592,$19,226, which amount is shown as a liability. At December 31, 2021 there was a balance of $402. The negative cash is due to the issuance of checks for operating expenses and the delayed receipt of funds to deposit. Our non-current assets are unchanged, as all property and equipment and patents have been fully depreciated.


Total liabilities decreasedincreased by $300,918$63,970 at March 31,September 30, 2022 due to the increase of on-demand notes, offset in part by the issuance of shares of restricted common stock in full satisfaction of obligations, both principal and interest, on convertible notes converted.  This decrease was offset in part by additional borrowings received from on-demand notesconverted, increased professional fees and the accrual of marketing fees.  accrued interest.


20 

INFLATION


We do not expect the impact of inflation to have a negative impact on our product sales or our operations for the next twelve months.



ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


Not applicable to smaller reporting companies.



ITEM 4. CONTROLS AND PROCEDURES


(a)Disclosure Controls and Procedures

(a)

Disclosure Controls and Procedures


As of the end of the period covered by this quarterly report, we carried out an evaluation of the effectiveness of our disclosure controls and procedures under the supervision and with the participation of our Chief Executive Officer, who also serves as our Principal Financial Officer. Our controls and procedures are designed to allow information required to be disclosed in our reports to be recorded, processed, summarized and reported within the specified periods, and accumulated and communicated to management to allow for timely decisions regarding required disclosure of material information. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives. Based upon the evaluation, our Chief Executive Officer concluded that our disclosure controls and procedures were not effective at that reasonable assurance level as of the end of the three-monthnine-month period ended March 31,September 30, 2022.


The material weaknesses relate to the limited number of persons responsible for the recording and reporting of financial information, the lack of separation of financial reporting duties, and the limited size of our management team in general. We are in the process of evaluating methods of improving our internal control over financial reporting, including the possible addition of financial reporting staff and the increased separation of financial reporting responsibility, and intend to implement such steps as are necessary and possible to correct these material weaknesses


(b)Changes in Internal Control over Financial Reporting


(b)

Changes in Internal Control over Financial Reporting


There have been no changes in internal control over financial reporting during the threenine months of 2022 that have materially affected, or are reasonably likely to materially affect our internal control over financial reporting.



PART II - OTHER INFORMATION


ITEM 1. LEGAL PROCEEDINGS


None.


ITEM 1A. RISK FACTORS


We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.




ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS


None.


ITEM 3. DEFAULTS UPON SENIOR SECURITIES


None.

21 


ITEM 4. MINE SAFETY DISCLOSURES


Not applicable.


ITEM 5. OTHER INFORMATION


None.


ITEM 6. EXHIBITS


Part I Exhibits


No.Description

No.31.1

Description

31.1

Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Clark M. Mower pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley


Part II Exhibits


No.Description

No.

Description

3(i).1

Certificate of Incorporation of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.1 for Form 10-QSB, filed August 4, 2006)

3(i).2

Certificate of Amendment to Flexpoint Certificate of Incorporation, dated October 11, 2019

(Incorporated by reference to exhibit 3(i).2 of Form 8-K, filed October 15, 2019)

3.2

Bylaws of Flexpoint Sensor, as amended (Incorporated by reference to exhibit 3.4 of Form 10-QSB, filed May 3, 2004)

10.1

Office Building Lease between Flexpoint Sensor Systems and FGBP, LLC, dated December 9, 2019 (Incorporated by reference to exhibit 10.1 of Form 10-K, filed March 30, 2020)

10.2

Exclusive License Agreement between Flexpoint Sensor Systems and subVo, LLC, dated June 19, 2019. (Incorporated by reference to exhibit 10.2 of Form 10-Q, filed August 14, 2019)

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Label Linkbase Document

101.PRE

XBRL Taxonomy Presentation Linkbase Document      

22 





SIGNATURES


In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, who is duly authorized.


FLEXPOINT SENSOR SYSTEMS, INC.


Date: May 16,November 14, 2022


/s/ Clark M. Mower

Clark M. Mower

President, Chief Executive Officer and Director,

Principal Financial Officer



20



23 

iso4217:USD xbrli:shares